Biomarkers in spinal cord compression Ethics and perspectives

Main Article Content

A. St. Iencean
A. Tascu
St. M. Iencean


The phosphorylated form of the high-molecular-weight neurofilament subunit NF-H (pNF-H) in serum or in cerebro-spinal fluid (CSF) is a specific lesional biomarker for spinal cord injury. The lesional biomarkers and the reaction biomarkers are both presented after several hours post-injury. The specific predictive patterns of lesional biomarkers could be used to aid clinicians with making a diagnosis and establishing a prognosis, and evaluating therapeutic interventions. Diagnosis, prognosis, and treatment guidance based on biomarker used as a predictive indicator can determine ethical difficulties by differentiated therapies in patients with spinal cord compression. At this point based on studies until today we cannot take a decision based on biomarker limiting the treatment of neurological recovery in patients with complete spinal cord injury because we do not know the complexity of the biological response to spinal cord compression.

Article Details

How to Cite
Iencean, A. S., Tascu, A., & Iencean, S. M. (2016). Biomarkers in spinal cord compression: Ethics and perspectives. Romanian Neurosurgery, 30(3), 317–320. Retrieved from
Author Biographies

A. St. Iencean

Neurosurgery, “Prof. N. Oblu” Emergency Hospital, Iasi, ROMANIA

A. Tascu

“Carol Davila” University of Medicine and Pharmacy, Bucharest, ROMANIA

St. M. Iencean

“Grigore T. Popa” University of Medicine and Pharmacy, Iasi, ROMANIA

Similar Articles

You may also start an advanced similarity search for this article.